Posted by jrbecker on May 9, 2003, at 12:44:40
In reply to Re: CRF Antagonists, posted by jrbecker on May 9, 2003, at 11:10:39
I should have also added Organon to that list.
> Have you called all of the other companies involved in CRF-1 pipeline research: Pfizer, Janssen(neurocrine's partner), GSK, Bristol-Meyer's Squibb?
>
>
>
>
> > Hi Pfinstegg,
> >
> > After ringing around I finally got the PM at Neurocrine to give me some information regarding the CRF Antagonist trials although Neurocrine are no longer doing them she said as follows:-
> >
> > I found out some info from a colleague at GSK. The CRF1 Antagonist patient
> > trials will not occur in the near future. Here is her recommendation for
> > searching the GSK website for trials with other GSK drugs:
> >
> > "...the next patient trials with any CRF1 backup will not be projected to
> > inititate until,....best case scenario......at least sometime in 2005. If
> > she'd be interested in looking at our web site, which would point her
> > possibly to other compound trials she may be interested in, she could check
> > out www.gsk.com under R&D. There are several links to different trials
> > under this.
> >
> > Right now we have clinical trials ongoing in depression for Lamictal,
> > Wellbutrin SR, Paxil CR, and several new compounds in development, however,
> > I'm limited as to how much info I can share on these beyond what is
> > currently on the website."
> >
> > I can't understand it, why are they still doing trials for lamictal, wellbutrin, Paxil which have been around for years and yet they're leaving the CRF antagonists until 2005.
> >
> >
> > Denise
>
>
poster:jrbecker
thread:225118
URL: http://www.dr-bob.org/babble/20030505/msgs/225408.html